Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation

Dominik Kraus(Roche (Switzerland)), Rainer Probstmeier(University of Bonn)
Cellular Oncology
June 11, 2018
Cited by 83


Related Papers